CEPHALEXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cephalexin, and what generic alternatives are available?
Cephalexin is a drug marketed by Alkem Labs Ltd, Anda Repository, Apothecon, Aurobindo Pharma, Barr, Belcher Pharms, Chartwell Rx, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Hikma Pharms, Vitarine, Yung Shin Pharm, and Aurobindo Pharma Ltd. and is included in fifty-two NDAs.
The generic ingredient in CEPHALEXIN is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cephalexin
A generic version of CEPHALEXIN was approved as cephalexin by TEVA on February 13th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEPHALEXIN?
- What are the global sales for CEPHALEXIN?
- What is Average Wholesale Price for CEPHALEXIN?
Summary for CEPHALEXIN
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 52 |
| Finished Product Suppliers / Packagers: | 38 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 64 |
| Patent Applications: | 4,861 |
| Drug Prices: | Drug price information for CEPHALEXIN |
| Drug Sales Revenues: | Drug sales revenues for CEPHALEXIN |
| What excipients (inactive ingredients) are in CEPHALEXIN? | CEPHALEXIN excipients list |
| DailyMed Link: | CEPHALEXIN at DailyMed |
See drug prices for CEPHALEXIN
Recent Clinical Trials for CEPHALEXIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brett A Faine | Phase 4 |
| Cairo University | Phase 4 |
| St. Louis University | Phase 4 |
Pharmacology for CEPHALEXIN
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEPHALEXIN
US Patents and Regulatory Information for CEPHALEXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yung Shin Pharm | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 065336-002 | Jul 25, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 062702-002 | Feb 13, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Stevens J | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 062870-001 | Mar 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 062987-001 | Jul 25, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 065234-002 | Aug 17, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Yoshitomi | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 062871-001 | Jul 5, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 062778-001 | Aug 6, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
